Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?

• Published in: Archives of medical research Vol. 51; no. 3; pp. 268 - 277
• Main Authors: Tolentino-Hernández, Suset J., Cruz-Antonio, Leticia, Pérez-Urizar, José, Cabrera-Fuentes, Héctor A., Castañeda-Hernández, Gilberto
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2020
• Subjects: Ciprofloxacin; Ethnic groups; Interethnic variability; Pharmacokinetics; Interethnic variability; Ciprofloxacin; Pharmacokinetics; Ethnic groups
• ISSN: 0188-4409; 1873-5487
• DOI: 10.1016/j.arcmed.2020.02.008

There is evidence that the pharmacokinetics of certain drugs in Mexicans may differ with respect to other ethnic groups. On the other hand, there is controversy about the existence of interethnic variability in the pharmacokinetics of ciprofloxacin. To study oral ciprofloxacin pharmacokinetics in Mexicans at various dose levels and make comparisons with other populations in order to gain insight on interethnic variability. Healthy Mexican volunteers received oral ciprofloxacin as 250 mg and 500 mg immediate-release tablets or a 1,000 mg extended-release formulation. Plasma concentration against time curves were constructed, and pharmacokinetic parameters were compared with those reported for other populations. Ciprofloxacin pharmacokinetics in Mexicans was linear and no significant differences between males and females were detected. When several populations were compared, it appeared that bioavailability in Mexicans was similar to that of Caucasians, being lower than that of Asians. These variations were attenuated when data were normalized by body weight. Ciprofloxacin pharmacokinetics exhibit interethnic variability, Asians exhibiting an increased bioavailability with regard to Mexicans and Caucasians. Data suggest that these differences are due to body weight.